
    
      A prospective, multicenter, randomized, sham-controlled, single-blind (participants) study to
      demonstrate the superiority of treatment with the ClariFix cryotherapy device for reducing
      symptoms when compared with a sham treatment in patients with chronic rhinitis. The ClariFix
      device is a Class II FDA-cleared medical device that is intended to be used as a cryosurgical
      tool for the destruction of unwanted tissue during surgical procedures, including in adults
      with chronic rhinitis.
    
  